Tell me more about the terifs
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
“Terifs” appears to refer to the sweeping tariff program enacted since January 2025 under the Trump administration, which includes broad IEEPA-based “fentanyl” and reciprocal tariffs and country‑ or product‑specific measures; the policy mix has produced visible declines in the monthly U.S. trade deficit but also generated legal challenges and lower‑than‑expected revenue (CBO projects more than a third of imports unaffected; New York Times reports lower deficit; Fortune and others cite revenue shortfalls) [1] [2] [3].
1. What the tariffs are and how they were justified — a legal and policy sketch
The administration deployed multiple authorities in 2025 to raise duties on imports: broad IEEPA orders tied to national emergencies (including a “fentanyl” justification) and other tools such as Section 301 and Section 232 actions; the policy covers country‑specific lists, product‑specific levies (including large ad valorem hikes and targeted measures like a 100% rate on certain cranes), and “reciprocal” sliding scales designed to ensure minimum combined rates (Congressional Research Service summary; tracker examples) [4] [5] [6].
2. Immediate economic effects — lower deficit, uneven coverage
Official and press reporting show a fall in the monthly U.S. trade deficit to its lowest level in five years after the tariff wave, a headline result cited by The New York Times; yet analysts and the Congressional Budget Office note important caveats: exemptions and refunds mean “more than a third of imports are unaffected” by the new rates, muting the coverage and altering the arithmetic of winners and losers [2] [1].
3. Revenue and macro expectations vs. reality
The administration forecasted very large tariff receipts; independent analysis and market reporting now find collections far below those expectations. The CBO and Pantheon Macro/fortune reporting show lower effective average tariff rates than projected and an estimated roughly $100 billion shortfall relative to early White House hopes, driven partly by substitution, exemptions and firms’ rerouting of trade [1] [3].
4. Evasion, rerouting and the transshipment problem
Private‑sector and think‑tank tracking shows exporters and importers responding: firms are re‑routing shipments, suppliers are shifting sourcing, and countries like Vietnam have seen surges in certain imports as goods are relabeled or transshipped to face lower rates. These behaviors reduce the tariffs’ bite, complicate enforcement and explain part of the revenue shortfall [3] [7].
5. Legal risk — courts and the Supreme Court’s looming role
Multiple courts have already questioned the administration’s legal basis, with recent appellate decisions finding parts of the policy exceed executive authority under IEEPA and returning questions to lower courts; The Economist and legal trackers report that roughly half the tariffs imposed under IEEPA face an imminent Supreme Court decision that could curtail presidential tariff powers [5] [8].
6. Business and labor impacts — mixed signals
Corporate reports and Fed commentary describe rising costs for some firms (one retailer reported ~20% higher costs), and analysts warn that higher input costs could force firms to reduce U.S. headcount in 2026. At the same time, proponents point to reduced imports and reshoring rhetoric; empirical effects differ across sectors because of exemptions [9] [1].
7. Diplomatic and dealmaking offsets
The administration has used tariffs both as pressure and as a bargaining chip: negotiators have struck partial truce agreements with several partners (including China on a temporary reduction of certain “fentanyl” tariffs and purchase commitments) and reached preliminary arrangements with countries such as Japan, the EU and others, producing targeted rollback or modulation of duties in some categories [4] [10].
8. Three competing narratives to watch
Supporters say tariffs restore leverage, cut the deficit and pressure foreign suppliers to curb illicit flows (administration framing cited in trackers and briefs). Critics argue the measures violate law, raise consumer and producer costs, and are porous to evasion—evidence cited includes court rulings, CBO estimates of exemptions and revenue misses described by Fortune and other outlets [4] [1] [3] [8].
9. What reporting does not yet settle
Available sources do not mention specific, verifiable nationwide “tariff dividend” payments actually delivered to citizens beyond administration claims of returning tariff proceeds; fact‑checking outlets report the administration said trillions were being collected but independent analyses show revenue shortfalls [11] [3]. Also, precise long‑run employment effects remain contested and not definitively resolved in current reporting [9].
10. Bottom line for readers
The “terifs” are a re‑engineered tariff regime with broad scope, clear short‑term trade‑flow effects and significant legal and compliance vulnerabilities. Watch three indicators that will determine the program’s future: court rulings on IEEPA authority, measured tariff revenue versus projections (CBO and independent analysts), and evidence of durable reshoring rather than temporary rerouting [8] [1] [3].